References
Rio J, Tintore M, Nos C, Tellez N, Galan I, Montalban X (2005) Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre. J Neurol 252:795–780
The IFNB Multiple Sclerosis Study Group and the UBC MS/MRI Analisys Group (1995) Interferon beta-1b in the treatment of MS: Final Outcome of the randomised controlled trial. Neurology 45:1277–1285
Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, et al. (1996) Intramuscular interferon®-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39:285–294
PRIMS Study Group (1998) Randomised double-blind placebo-controlled study of interferon®-1a in relapsing- remitting multiple sclerosis. Lancet 352:1498–1504
The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655–661
Ioannidis JPA (2005) Why most published research findings are false. PloS Medicine 2:696–701
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rio, J., Montalban, X. Reply to D. S. Goodin. J Neurol 253, 949 (2006). https://doi.org/10.1007/s00415-006-0098-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0098-y